A61K 49 - Preparations for testing in vivo

Patents for A61K 49 - Preparations for testing in vivo (35,376)
10/2007
10/25/2007	WO2007119771A1 Test agent for diagnosing dyspepsia
10/25/2007	WO2007119103A1 Labeled macrophages and methods of use thereof
10/25/2007	WO2007119098A2 Use of an nmda receptor antagonist the treatment of tinnitus induced by cochlear excitotoxicity
10/25/2007	WO2007118884A1 Magnetic nanoparticles compositions and uses thereof
10/25/2007	US20070249641 Adenosine a3 receptor modulators
10/25/2007	US20070248547 Cascade macromolecular contrast agents for medical imaging
10/25/2007	US20070248546 Clinical algorithm for excluding patients identified in virtual imaging
10/25/2007	US20070248545 Use of the receptor GPR86
10/25/2007	US20070248544 Mullerian inhibiting substance levels and ovarian response
10/25/2007	US20070248543 Chicken Deoxycytidine and Deoxyadenosine Kinase Enzymes and Their Use
10/25/2007	US20070248542 Devices and methods for individualized detection of nutrient imbalance via olfactory system
10/25/2007	US20070248541 Liposome
10/25/2007	US20070248540 Biochemical methods for measuring metabolic fitness of tissues or whole organisms
10/25/2007	US20070248537 Compositions and Methods for Cellular Imaging and Therapy
10/25/2007	CA2649454A1 Methods of modeling migraine pain and identifying candidate compounds for the treatment of migraine
10/25/2007	CA2649333A1 Cellular labeling and quantification for nuclear magnetic resonance techniques
10/25/2007	CA2649262A1 Test agent for diagnosing dyspepsia
10/25/2007	CA2649207A1 Magnetic nanoparticles compositions and uses thereof
10/25/2007	CA2636129A1 Detection of soluble adiponectin receptor peptides and use in diagnostics and therapeutics
10/25/2007	CA2617661A1 Methods for the treatment of tinnitus induced by cochlear excitotoxicity
10/24/2007	EP1847275A1 A high-intensity focused ultrasound plasmid adjuvant and its use
10/24/2007	EP1847267A2 Method of photodynamic diagnosis for vascular diseases
10/24/2007	EP1846042A2 Conjugates for dual imaging and radiochemotherapy: composition, manufacturing, and applications
10/24/2007	EP1846024A2 Mycobacterial mutants affecting host apoptosis
10/24/2007	EP1465669B1 Metal complex compounds
10/24/2007	CN100344606C Iodine Ioxilan preparation method
10/23/2007	US7285289 Nanoparticle vaccines
10/23/2007	CA2341946C Polypetides and compositions prepared from the amplification of the hiv-2 and siv-type retrovirus genome,
10/23/2007	CA2244209C Improved concentrated injection and infusion solutions for intravenous administration
10/18/2007	WO2007118249A2 Personal electronic device carrier
10/18/2007	WO2007118202A2 Learning-based recommendation system incorporating collaborative filtering and feedback
10/18/2007	WO2007116954A2 Inorganic nanoparticle comprising an active substance immobilized on the surface and a polymer
10/18/2007	WO2007116951A1 Drug-immobilized inorganic nanoparticle
10/18/2007	WO2007116808A1 Virus particle-like structure and pharmaceutical preparation comprising the same
10/18/2007	WO2007095871A3 Superparamagnetic nanoparticles based on iron oxides with modified surface, method of their preparation and application
10/18/2007	WO2007069909A3 Method to produce hyperpolarised carboxylates of organic amines
10/18/2007	WO2007064226A3 Method of dynamic nuclear polarisation (dnp) using a trityl radical and a paramagnetic metal ion
10/18/2007	WO2007031910A3 Multiple contrast agent injection for imaging
10/18/2007	US20070244316 Optically pure and enriched isomers of chelating ligands and contrast agents
10/18/2007	US20070244198 Carboxylic Derivatives
10/18/2007	US20070244037 Human Chemokine HCC-1 Polypeptides To Improve Stem Cell Transplantation
10/18/2007	US20070243139 A dimer of two polypeptides having specificity andreceptivity for different epitopes on a protein-tyrosinekinase receptor; linked by spacers; synergistic; contrast agents for radition imaging and therapy; biodrugs; hepatocyte growth factor receptor/cMET complex target; antitumor, -carcinogenic agents
10/18/2007	US20070243138 Hollow microspheres with controlled fragility for medical use
10/18/2007	US20070243137 Cell and sub-cell methods for imaging and therapy
10/18/2007	US20070243136 Methods and Compositions for Imaging
10/18/2007	US20070243135 Method of treating fetal growth retardation and placental ischaemia and insufficiency
10/18/2007	CA2649182A1 Methods and compositions related to adenoassociated virus-phage particles
10/18/2007	CA2648691A1 Optical coherence tomographic detection of cells and killing of the same
10/18/2007	CA2648585A1 Stabilized immune modulatory rna (simra) compounds for tlr7 and tlr8
10/17/2007	EP1844142A2 Vectors and methods for genetic immunization
10/17/2007	EP1276770B1 Proteins with a high immunoreactivity and a method for the production thereof
10/17/2007	EP1073473B1 Improvements in or relating to contrast agents
10/17/2007	EP1017425B1 Improved methods for diagnostic imaging involving the use of a contrast agent and a coronary vasodilator
10/17/2007	CN101053814A Multiple responsive high molecular microcapsule and preparation method thereof
10/16/2007	US7282567 Monoclonal antibody hPAM4
10/16/2007	US7282343 Administering psoralen ultraviolet A (PUVA) in combination with fluoroquinolone, a macrolide, tetracycline, a tetracycline derivative, penicillin, or penicillin derivative; mycosis fungoides, Sezary syndrome, lymphomatoid papillosis, Ki-1 lymphoma, exfoliative exematous rash, and digitate parapsoriasis
10/16/2007	US7282340 Methods for identifying an analog that promotes nerve regeneration
10/16/2007	US7282223 Kit for cleaning the digestive tract e.g. prior to colonoscopy or surgical procedure; provides calories for daily routine while minimizing stool formation
10/16/2007	US7281393 Adapting a heat exchanger tube with an interior surface and an exterior surface to permit gas flow; applying magnetic field; controllably refrigerating exterior surface of heat exchanger tube by exposing a controllably larger area of tube as freezing progresses
10/11/2007	WO2007115291A2 Tissue markings with discrete absorption particles
10/11/2007	WO2007115121A2 Ofdma transmitter and method of transmitting ofdma signals using compress-decompress modulation
10/11/2007	WO2007113839A2 Device, system and method for in-vivo analysis
10/11/2007	WO2007113721A2 Systems and methods for cell measurement utilizing ultrashort t2* relaxometry
10/11/2007	WO2007113386A1 Peptide conjugates
10/11/2007	WO2007113385A1 Diagnostic and therapeutic agents
10/11/2007	WO2007070827A3 Contrast agents for myocardium perfusion imaging
10/11/2007	WO2007024568A3 Method of effecting a mammalian model of sepsis, severe sepsis, or septic shock
10/11/2007	WO2007024368A3 Compositions and methods to control angiogenesis with cupredoxins
10/11/2007	WO2006138160A3 Amyloid beta protein channel structure and uses thereof indentifying potential drug molecules for neurodegenerative diseases
10/11/2007	US20070238767 e.g. 4,5-Dihydro-2-(2,4-dihydroxyphenyl)-thiazole-4(S)-carboxylic acid; ferrochelatase; thalassemia, anemia; diagnosing and treating pathological conditions associated with excess of trivalent metals (such as Fe, Al and Cr)
10/11/2007	US20070237721 Targeted mr imaging agents
10/11/2007	US20070237720 Embolic prosthesis for treatment of vascular aneurysm
10/11/2007	US20070237719 Method and system for monitoring and analyzing compliance with internal dosing regimen
10/11/2007	US20070237717 Methods for Selection of Subjects for Multiple Sclerosis Therapy
10/11/2007	US20070237716 Compositions and methods for reverse transcriptase-polymerase chain reaction (rt-pcr) of human b-retrovirus
10/11/2007	US20070237715 Method And Apparatus For Tear Film Measurement
10/10/2007	EP1842560A1 A high-intensity focused ultrasound adjuvant and the screening method thereof
10/10/2007	EP1842554A1 Coated magnetic particle containing preparation, process for producing the same and diagnostic therapeutic system
10/10/2007	EP1842542A1 Novel PPAR ligands that do not cause fluid retention, edema or congestive heart failure
10/10/2007	EP1841355A1 Method of detecting myocardial dysfunction in patients having a history of asthma or bronchospasm
10/10/2007	EP1414994B1 Vaccinia virus for diagnosis and therapy of tumors
10/10/2007	EP1071473B1 Acetic acid as a signal enhancing contrast agent in fluorescence spectroscopy
10/10/2007	CN100341948C Heavier halogen atom subsituted squa glucoside dye, its producing process and it's used as sensitizing agent in the therapy of optical dynamic and industrial application
10/10/2007	CN100341883C Calcium complex of phosphorus contg. ethylenediamine derivs.
10/10/2007	CN100341581C Method of thalidomide for effective interventing oral cancer in animal model
10/10/2007	CN100341580C Agents for measuring pyrimidine metabolizability
10/10/2007	CN100341519C Medical use of engrafted nanometer carbon
10/09/2007	US7279170 Recombinant polypeptides, which can be used as purified antigens for the detection and control of tuberculosis
10/09/2007	US7279150 Nanoparticle emulsion; magnetic resonance imaging; antiinflammatory agents; antitumor agents
10/09/2007	US7279149 Amino acid composition with increased blood brain barrier permeability
10/04/2007	WO2007112100A2 Highly fluorinated oils and surfactants and methods of making and using same
10/04/2007	WO2007111702A2 Discrete tunable sensing elements and compositions for measuring and reporting status and/or product performance
10/04/2007	WO2007111179A1 Diagnostic imaging agent for incurable neuron disease
10/04/2007	WO2007110867A2 Implantable sensor
10/04/2007	WO2007110804A2 Diagnostic systems and methods utilizing probe-ions exhibiting photon avalanche effect
10/04/2007	WO2007110629A1 Inhibitors of protein aggregation
10/04/2007	WO2007028005A3 Biomarkers and methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators
10/04/2007	WO2007008080A3 Optical imaging contrast agents
10/04/2007	WO2006135879A3 Diagnosis and prognosis of diabetes
10/04/2007	WO2004069193A3 Methods and compositions for inhibiting cholesterol uptake

1 ... 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 ... 354